Trial AMPlify Designs a Multi Language Clinical Trial Site for Vivet

Jonathan Eilberg • August 5, 2022

Trial AMPlify, a leading clinical trial digital advertising agency located in Boston, MA, designed and developed a multi-language website to promote a new Wilson's Disease gene therapy study across the US and Europe.

Multi language clinical trial website

Trial AMPlify, a division of Boston Web Partners, launches a new multi-language clinical trial website for Vivet Therapeutics to study a new gene therapy to address Wilson's Disease. The disease is caused by mutations in a gene called ATP7B. VTX-801.


The website design was developed on an easy to edit platform without the need for constant plugin maintenance or theme updates. Site is hosted on Amazon (AWS) servers to ensure fast page loading. 90% of the Top 10 global biopharma companies use AWS.


Unlike other web design agencies, Trial AMPlify is able to eliminate the concern over WordPress malware attacks, and GDPR plugin compliance issues.


SEO best practices were implemented to help the site to rank higher in Google searches over time. While SEO is taking hold, a Google Ads campaign was launched to help drive web visitor traffic to the site immediately to increase subject enrollment across the US and Europe.


>> Click here to view the site - www.gatewaytrialwilsondisease.com



 

Patient Recruitment Agency

Our Role as a Patient Recruitment Company

By Jonathan Eilberg • January 23, 2025
Trial AMPlify helps define what a patient recruitment agency does and the ways it can help sponsors and CROs enroll eligible and diverse study subjects.
Plaque Psoriasis

Trial AMPlify Launches a Clinical Trial Website for Alumis

By Jonathan Eilberg • January 15, 2025
Trial AMPlify, a leader in clinical trial landing page design, launches a study site for Alumis to investigate a new psoriasis medication.
Clinical Trial Marketing

Clinical Trial Marketing Best Practices for 2025

By Jonathan Eilberg • December 22, 2024
Clinical trial marketing is critical for building awareness, trust and credibility when announcing and promoting studies, but most sponsors skip this step.
Advantages of a dedicated clinical trial website versus using clinicaltrials.gov

8 Advantages of Promoting a Dedicated Clinical Trial Website vs. Your CT.gov Listing

By Jonathan Eilberg • October 18, 2024
Trial AMPlify explores the reasons why you should be using a dedicated clinical trial website versus your clinicaltrials.gov as the face of your study for patient recruitment. Learn more
Family of a clinical trial patient discussing a study

Joining a Clinical Trial: A Family Decision

By Jon Eilberg • April 28, 2024
Trial AMPlify makes the case that a clinical trial is a family decision and that it may involve a spouse, sibling, or parent who is opposed to joining a study.
Woman patient refusing to join a clinical trial

Why Patients Refuse to Join a Clinical Trial and What Sponsors Can Do About It.

By Jonathan Eilberg • December 16, 2023
Trial AMPlify examines why people refuse to join clinical trials and the critical role patient recruitment firms play in increasing enrollment. Learn more
Clinical Trial Manager

Why So Many Patient Recruitment Campaigns Fail, and What Sponsors Can Do Differently to Improve Enrollment.

By Jonathan Eilberg • December 4, 2023
Trial AMPlify examines why so many clinical trial patient recruitment campaigns fail and what can be done to help increase subject enrollment. Learn More
Clinical Trial Patient Recruitment Agency Team

The Definitive Clinical Trial Patient Recruitment Glossary of Terms

November 14, 2023
Trial AMPlify presents a list of clinical trial patient recruitment terms for when a definition might escape you. Print the document for quick reference.
Patient recruitment online questionnaires do not work

The Problem with Online Questionnaires in Clinical Trial Enrollment

By Jon Eilberg • May 29, 2023
Trial AMPlify explains why forcing patients to take online surveys hinders the ability to attract subjects and can hurt the success of a study.
Patient Recruitment Website Traffic Graph

Now is Not the Time to Push Biotech Firms to the Financial Limit

By Trial AMPlify • May 5, 2023
Trial AMPlify, a leader in clinical trial patient recruitment makes a case to help biotech’s launch studies more quickly in these tough financial times.
More Posts
Share by: